Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 5Uterine Cervical Dysplasia 3Precancerous Conditions 3Papillomavirus Infections 3Atypical Squamous Cells of the Cervix 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 35Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 23Papillomavirus Vaccines 14Data Collection 7Blood Specimen Collection 7Vaccines 6Vaccines, Synthetic 5Educational Status 5Radiotherapy, Intensity-Modulated 4Human Papillomavirus Recombinant Vaccine nonavalent 4Early Intervention, Educational 4Vaginal Smears 3Surveys and Questionnaires 3Polymerase Chain Reaction 3Paclitaxel 3Methods 3Engerix-B 3Colposcopy 3Cisplatin 3halofantrine 2fludarabine phosphate 2fludarabine 2aldesleukin 2Watchful Waiting 2Taxes 2Patient Navigation 2Papanicolaou Test 2Observation 2Light Coagulation 2Imiquimod 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Papillomavirus Infections × Vaginal Smears × Clear all
NCT01550783 2020-07-31

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

University of Washington

Phase NA Completed
1,335 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT04072913 2019-08-28

MMP-HPV

University Hospital, Bordeaux

Phase NA Completed
216 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00977392 2013-08-07

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

National Cancer Institute (NCI)

Completed
3,000 enrolled
Other neoplasm

Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡